NCT04411147View on ClinicalTrials.gov

A Longitudinal Study of COVID-19 Sequelae and Immunity

Active, not recruitingOBSERVATIONAL

Enrollment

583

Participants

Timeline

Start Date

June 17, 2020

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

COVID-19

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH